I encourage you to look into the MP in great detail. If you have questions about the treatment you can post them at the following website:

http://www.curemyth1.org (Th1 refers to diseases caused by L-form bacteria, hence the name Cure My Th1). Your questions will be answered free of charge by patients advocates, some of them who used the MP to recover from Lyme.

I also encourage you to get on the MP study site (www.marshallprotocol.com) and look up other members with Lyme disease who have been on the treatment for a while. Email them about their experience with the MP or even ask if you can chat over the phone. Getting feedback straight from the patients themselves is a great way to learn more about the treatment.

I will be putting up another interview soon with a woman who had a bad case of Lyme and is doing very well now thanks to the MP. Be sure to check back in a few days to read that piece.

Best,

Amy

Thanks,

Cherie

I don’t know much about rife machines but from what I have been told they target few of the actual L-form bacteria causing these Th1 diseases. Dr. Marshall actually puts L-form bacteria into a larger category of persistent, stealth bacteria which he terms the “Th1 pathogens.” These bacteria, many of which are found in bioflims and communities we may not even understand at this point, very likely don’t even have a spirochete form for a rife machine to target. Also, there is question as to whether spirochetes are even common in the body as they are certainly produced in the lab, but may not be commonly formed in vivo. I have never heard of anyone truly recovering from Lyme using a rife machine probably for the above reasons. My guess is that the machines are better at targeting bacterial species that act as co-infections but not the Th1 pathogens themselves.

I know Brian Rosner wrote his book with the best of intentions, but it makes me sad to see such an intelligent person clump nine other treatments into his book that mentions the MP, none of which come close to having the scientific base that the MP does If he truly understood the MP then he would know that there is only one treatment for Lyme – the MP. Furthermore, he would know that adapting the MP, even with something like a Rife machine that seems to be helpful could have detrimental consequences that we don’t know about. One of the most important things about the MP is that it must be done exactly as stated, never combined with other therapies.

As Marshall has stated, “We have to remember that there are many species we are fighting against. Second, the immune system is so finely balanced between not killing them, and killing them, so that small changes to our lifestyle, or to our food, or caused by other drugs we are taking, might stop the immune system from killing the bacteria.”

On a separate note, the focus of the first study to sequence the genomes of individual cells would be done on a cohort of patients with fibromyalgia. That trial is still in the works as Marshall doesn’t have a lab yet, so I think doing the same thing with cancer would be far off. In terms of therapy, I believe the MP could go a long way in curbing or eliminating cancer. Yes, other factors may be involved but the presence of L-form bacteria is probably the driving factor, especially since it is now accepted by mainstream medicine that cancer is indeed an inflammatory disease. I think we may see that as people use the MP for more and more diseases other then cancer, cancer rates drop or even disappear completely.

I believe Markova is right. We should work on creating drugs that prevent the formation of L-form bacteria in the first place. Many times L-form bacteria are formed when classical bacteria are exposed to certain environmental factors – some we are unsure of, the beta-lactam antibiotics are certainly one of them. So at least whenever anyone gets an acute infection, they could be given a drug that would prevent the classical bacteria that have infected them from turning into the L-form.

Best,

Amy

Royal Rife (1888-1971) did research on treating cancer using electomagnetic radiation. It turns out that you can treat infections as well. The devices are called Rife Machines and were invented by Rife around 1930 and spontaneously rediscovered by other backyard scientists decades later.. As far as I am able to tell, Rife Machines do work on irregularly shaped micro organisms and show great effect in treating Lyme spirochetes under the microscope as well as irregular L-forms. They work by vibrating the organism or its organelles at resonante frequencies causing the to disassemble. There is a concern, though, that they are ineffective against spherical forms which do not resonate so well. Brian Rosner, in evaluating Rife machines, stated that Rife made him better but the MP took him over the top in treating his Lyme disease. He wrote two books, one is called the Top Ten Lyme Treatments.

Sorry for that digression, but my point is if the research can’t be done step by logical step then approach it from the treatment angle as Rife did. Unfortunately his lab and offices were mysteriously destroyed or raided by authorities and he fled to Mexico, his colleagues went to jail. One must be careful when working outside the box. Interesting reading, but I am sure you are busy enough as it is!

So, where is Dr. Marshall taking the genomic research. Its not hard to believe that bacterial DNA ends up in the human genome, but translating that to cancer sound like a giant leap to me. I don’t know much about carcinogenesis, so maybe the leap won’t be so far. Then you still have to create a therapy.Do you know what Marshall’s thinking is on this?

Speaking of therapies, I was intrigued by the Bulgarian scientist’s strategy of preventing morphogenesis to L forms from invasive forms as a therapy.. I can’t imagine that there will be a sequence of events that will apply to more than one species that could be targeted by a pharmaceutical. Genomics might help there.
Did she elaborate much on L-forms and cancer?

Amy, no need of a reply, just wanted you to know your work is so appreciated, informative and stimulating. God Bless you. Eric

You are absolutely right about the importance of Cantwell’s work. But as far as I know, Cantwell never did any experiments in which he took the bacteria he had cultured from tissue samples of people with cancer and then tried to isolate the pathogens and infect animals. So he wouldn’t be able to discuss that sort of experiment in a follow-up interview.

I believe that Lida Mattaman and certainly Emil Wirostko did conduct experiments in which they deliberately infected rats with L-form bacteria. In my article “Inflammation, vision, and bacteria” I describe a study in which Witrosko injected mice with the same species of L-form bacteria he had detected in his many of his patient’s eyes and found that cataracts developed in the eyes of 14 of the 15 mice who had been exposed to the cell wall deficient forms, whereas no cataracts developed in the eyes of 200 control mice that had not come in contact with the pathogens. But this study didn’t seem to cause much, if any, of an uproar among mainstream researchers.

I don’t think anyone has ever tried to take cancer-causing L-forms and inject them into laboratory animals. In my opinion, there are some problems with this type of study design. First and foremost is the fact that the murine immune system and VDR are substantially different from that of humans. See my article:

“Of mice and men: are the scientific studies you read accurate?

http://bacteriality.com/2007/11/07/mice/

Since much of the way L-form bacteria invoke disease is by affecting the immune system, there is no guarantee that rats and humans would even respond in the same way to a certain L-form species. Other animals could be used, but their VDRs still differ substantially from that of humans, and ethical issues begin to arise.

The other problem I foresee with these type of studies is contamination bias. I can see it right now – mainstream medicine rejecting these studies because the animals in the experiment could have been exposed to other pathogens or something along those lines. At least that’s a reason many mainstream researchers have used to dismiss most of Mattman and other L-form researchers laboratory work.

So I’d say the best way to prove that L-form bacteria cause cancer would be to use new molecular tools that are becoming available to study bacterial genomes. You can take individual cells from a person with cancer and sequence the DNA. Then you can find sequences of bacterial DNA that have been incorporated into their DNA.

Dr. Marshall is already trying to get this type of experiment rolling – although the first group of patients he plans to use will have fibromyalgia, not cancer. But if the first study goes well, it could easily lead to the same type of study being conducted in patients with other diseases.

Marshall actually has a ‘deal’ with the Human Genome project to do this sequencing of single cells. The problem is that he just needs a team of post-docs and a lab to do all the hard work. So there will have to be a little more interest on the part of other scientists before this research can start to take place.

In the meantime, I know that Gerald Domingue is also trying to encourage some young researchers to use new molecular tools to study L-form. If he succeeds maybe some of them might want to work with Marshall?

Well see….

Amy

Naturally, the ultimate experiment of innoculating humans with L-forms and watching for cancer can never be done, but work on animal models could take Dr. Cantwell’s ideas a long way. If this has been done already, I think the interview would be a great follow up to this one.

You are doing great work and providing a wonderful service to all by exposing them to alternative viewpoints with the requsite science to back them up. keep it up!!!!!! Eric